Osaic Holdings
DYN icon

Osaic Holdings’s Dyne Therapeutics DYN Stock Holding History

Osaic Holdings’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5K Sell
1,239
-51
-4% -$948 ﹤0.01% 5918
2026
Q1 		$23.4K Buy
1,290
+655
+103% +$11.3K ﹤0.01% 5755
2025
Q4 		$12.4K Sell
635
-6
-0.9% -$114 ﹤0.01% 6200
2025
Q3 		$8.16K Buy
641
+621
+3,105% +$7.08K ﹤0.01% 6489
2025
Q2 		$190 Sell
20
-7
-26% -$77 ﹤0.01% 7508
2025
Q1 		$282 Buy
27
+12
+80% +$172 ﹤0.01% 7113
2024
Q4 		$353 Sell
15
-8,645
-100% -$256K ﹤0.01% 7085
2024
Q3 		$311K Buy
8,660
+8,614
+18,726% +$343K ﹤0.01% 3284
2024
Q2 		$1.62K Sell
46
-32,364
-100% -$940K ﹤0.01% 6672
2024
Q1 		$920K Buy
+32,410
New +$733K ﹤0.01% 2419

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Osaic Holdings's DYN Position: Q2 2026 in Review

Osaic Holdings reduced its Dyne Therapeutics (DYN) stake by 4% in Q2 2026, selling an estimated $948 and leaving 1,239 shares worth $27.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5918.

Osaic Holdings first reported a position in DYN in Q1 2024 and has held it in 10 quarters since. The position peaked at $920K in Q1 2024. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Osaic Holdings held 1,239 shares of Dyne Therapeutics worth $27.5K as of Q2 2026.
  • Osaic Holdings sold 51 Dyne Therapeutics shares in Q2 2026, an estimated $948.
  • Dyne Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5918 holding.
  • Osaic Holdings first reported a position in Dyne Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • Osaic Holdings's Dyne Therapeutics position peaked at $920K in Q1 2024.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.